Search

everythinglearnresearchcommunity

for

Search:↓

Dermatologists are crucial for managing skin side effects in metastatic melanoma patients using vemurafenib and ipilimumab.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

Most patients experienced mild to moderate skin problems during a trial for a desmoid tumor treatment.

The drug IPI-926 is safe at 160 mg daily and may help treat certain tumors, especially basal cell carcinoma.

Inhibitors of 11β-HSD1 show potential for treating type 2 diabetes but require more testing for safety and effectiveness.

Tofacitinib and ruxolitinib are effective and safe for treating various autoimmune skin and joint disorders.

CDK4/6 inhibitors have improved treatment outcomes for certain advanced breast cancer patients.

Oral JAK inhibitors are safe for alopecia areata, but baricitinib may cause more acne and infections.

TGF-β inhibitors may help treat liver fibrosis by targeting various pathways.

TNF-alpha inhibitors can cause various immune-related skin issues.

Certain leukemia drugs can cause severe skin reactions that may require stopping treatment.

Prostaglandin D2 blocks new hair growth after skin injury through the Gpr44 receptor.

Targeting NETs may help reduce fibrosis in Crohn's disease.

Platelet-derived chemokines help muscle healing by attracting neutrophils to injured areas.

ZD1839, a cancer drug, can cause mild skin rashes that are treatable without stopping the medication.

Six key genes can predict bladder cancer outcomes and may serve as prognostic biomarkers.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

TNF-α blockers and IL inhibitors improve symptoms in most patients with severe scalp condition, but more research is needed.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Chemotherapy and radiotherapy can cause skin side effects like rashes, hair loss, and nail changes, which are usually managed with conservative treatments.

A man with multiple autoimmune diseases developed liver injury from azathioprine, but his liver improved after stopping the drug.

Stem cell therapy from umbilical cords may help treat atopic dermatitis.

Janus kinase inhibitors reduce inflammation markers in severe alopecia areata patients.

Bacteria can help skin regenerate through a process called IL-1β signaling.

The document explains various skin conditions and their treatments.

Apremilast may help treat hair loss in alopecia areata.

Some drugs, especially biologics, can cause skin reactions that look like other skin diseases, and stopping the drug usually helps clear up these reactions.

Hormonal therapy is effective for treating acne in adult women, especially with signs of high androgen levels.

Treatment with biologic agents can significantly improve psoriasis symptoms, and blood biomarkers could potentially predict individual patient's response to treatment.

Baricitinib helped a woman with severe hair loss regrow almost all her hair without side effects.